期刊文献+

心功能与慢性阻塞性肺疾病伴肺心病患者NT-pro BNP和血脂水平的相关性研究 被引量:22

Relationship study between heart function and NT-pro BNP and blood lipid levels in patients with COPD complicated with CP
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease,慢阻肺),伴慢性肺源性心脏病(Cor Pulmonale,CP)患者心功能与N-末端脑钠肽前体(N-terminal pro-B-style natriuretic peptide,NT-pro BNP)和血脂水平的相关性研究。方法荧光免疫分析和生化法测定了188例慢阻肺伴肺心病患者(心功能Ⅰ级-Ⅳ级)、123例慢阻肺患者和72例正常对照组血浆NT-pro BNP和血脂[TC、TG、HDL-C、LDL-C和LP(a)]水平,并进行对比性研究。结果 188例慢阻肺伴肺心病患者血浆NT-pro BNP水平随心功能Ⅰ级-Ⅳ级的严重程度而增高,较之72例正常对照组和123例慢阻肺患者均明确增高(P分别为<0.05、<0.01、<0.001和<0.001)。123例慢阻肺患者较之正常对照组无明显差异(P>0.05)。188例慢阻肺伴肺心病患者血清TC、TG、HDL-C和LP(a)水平随心功能Ⅰ级-Ⅳ级的严重程度而降低,较之72例正常对照组和123例慢阻肺患者均明显降低(P>0.05-<0.001)。123例慢阻肺患者血清TC、TG和LDL-C水平较之正常对照组无明显差异(P均>0.05),HDL-C和LP(a)水平稍降低(P均<0.05)。结论血浆NT-pro BNP水平测定有助于鉴别肺源性和心源性呼吸困难,慢阻肺伴肺心病患者血浆NT-pro BNP随肺心病的严重程度而增高,血清TC、TG、HDL-C和LP(a)随肺心病严重程度而降低,有利于慢阻肺伴肺心病患者的早期诊断和及时治疗。 Objective To explore the relationship between heart function and NT-pro BNP and blood lipid levels in patients with COPD complicated with CP. Methods The plasma NT-pro BNP and blood lipid([TC、TG、HDL-C、LDL-CandLP(a)] )levels were determined in 188 COPD patients complicated with CP (heart function I-IV stage), 123 patients with COPD and 72 normal controls by immunofluorescence assay and biochemistry. Results The plasma NT-pro BNP level in 188 COPD patients complicated with CP increased with severity and significantly higher than those in 72 normal controls and in 123 COPD patients (P 〈0. 05, P 〈0.01, P 〈0. 001 and P 〈0. 001 respectively), but there was no significant difference between the COPD group and the control group (P 〉0. 05). The serum levels of TC, TG, HDL-C and LP(a) in COPD patients complicated with CP decreased with severity and significantly lower than those in the control group and the COPD group (P 〉0. 05 - P 〈0. 001 ). There was no sig- nitieant difference in serum TC, TG and LDL-C levels between the COPD group and the control group ( all P 〉 0. 05). Conclusion NT-pro BNP level can help to differentiate pulmonary dyspnea and cardiac dyspnea. Serum NT-pro BNP level increases with severity, and serum TC, TG, HDL-C and LP(a) decrease in COPD patients com- plicated with CP, which is helpful for early diagnosis and therapy.
出处 《临床肺科杂志》 2016年第12期2261-2264,共4页 Journal of Clinical Pulmonary Medicine
关键词 慢阻肺伴肺源性心脏病 心功能 N-末端脑钠肽前体 血脂 早期诊断 严重程度 COPD complicated with CP heart function N-terminal pro-B-style natriuretic peptide ( NT-proBNP) blood lipid early diagnosis severity
  • 相关文献

参考文献2

二级参考文献34

  • 1Danesh JD, Collins R, Peto R. Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies [ J ]. Circulation, 2000, 102 ( 10 ) : 1082-2000.
  • 2Rifai N, Ma J, Sacks FM, et al. Apolipoprotein(a) size and lipoprotein(a) Joncentration and future risk of angina pectoris with evidence of severe coronary atherosclemsis in men : The Physicians" Health Study [ J ]. Clin Chem, 2004, 50(8) :1364-1371.
  • 3Klausen IC, Sjol A, Hansen PS, et al. Apolipoprotein(a) isoforms and coro- nary heart disease in men. A nested case-control study [ J ]. Atherosclerosis, 1997,132( 1 ) : 77-84.
  • 4Thorgersen AM, Soderberg S, Jansson JH, et al. Interactions between fibrinol- ysis, lipoproteins, and leptin related to a first myocardial infarction [ J ]. Eur J Cardiovasc Prevent & Rehab,2004,11 ( 1 ) : 33-40.
  • 5Bostom AG, Cupples, LA, Jenner JL, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger [ J ]. JAMA, 1996,276(7) : 544-548.
  • 6Gaw A, Murray HM, Brown EA. Plasma lipoprotein (a) {Lp(a) I concentra- tions and cardiovascular events in the elderly: evidence from the Prospective Study of Pravastatin in the elderly at risk (PROSPER) [ J ]. Atherosclerosis, 2005,180(2) : 381-388.
  • 7Auer J, Rammer M, Berent R, et al. Lack of association between plasma lipo- protein(a) concentration and the presence or absence of coronary atherosclero- sis[J]. Acta Cardiol,2002,57(6) : 409-414.
  • 8Jaubiainen M, Koskinen P, Ehnholm C, et al. Lipoprotein (a) and coronary heart disease risk : a nested case-control study of the Helsinki Heart Study par- ticipants[J]. Atherosclerosis,1991,89(1) : 59-67.
  • 9Bostom AG, Gafnon DR, Cupples LA, et al. A prospective investigation of el- evated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study [ J ]. Circulation, 1994, 90 ( 4 ) : 1688-1695.
  • 10Wild SH, Fortmann SP, Marcovina SM. A prospective casecontrol study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford five-city project participants [ J ]. Arterioscler Tbromb Vasc Biol, 1997,17(2) : 239-245.

共引文献3

同被引文献164

引证文献22

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部